Solutions · Payers & self-insured employers

Stop inferring effectiveness from the claims you already paid.

A claim records that a procedure was billed, not whether the patient got better, and it stops when the payment window closes. Circles record the whole episode, from baseline to long-term outcome, each entry attested at its source, so coverage and contracting rest on evidence you can trace.

The executive case

Return, liability, compliance — answered up front.

Return

Coverage, benefit design and prior authorization rest on claims that cannot show whether a procedure worked. A Circles Dataset ties spend to attested outcomes across the episode, so those decisions, and the outcomes-based contracts payers are now pledging to offer, rest on evidence instead of inference.

Liability

Medicare Advantage plans made 52.8 million prior authorization determinations in 2024, and 80.7% of appealed denials were overturned. OIG found that 13% of the denials it reviewed met Medicare coverage rules. A documented episode lets a medical-policy decision be defended record by record.

Compliance

Since January 2026, prior authorization decisions are due within 72 hours for urgent and seven days for standard requests; payer interfaces follow in January 2027. Circles answers are built from FHIR resources, and each carries the attesting clinician and time, ready for that exchange.

5 solutions for payers & plan sponsors

Why payers and self-insured employers partner with RegenMed.

Each runs on the same four pillars: the Observational Protocol, the Circle, the closed system and the technical stack. The detail sits in the linked white papers.

1

Coverage decisions on longitudinal outcomes

Judge a procedure or drug on attested outcomes across the whole episode, not on the fact that it was billed.

Medical policy is written against published trials and then administered against claims, which describe utilization rather than benefit. A Circle states the endpoint before the first case is enrolled and captures it at each follow-up visit, so a policy committee can read effectiveness in the population it actually covers. Every value resolves to an attesting clinician and a timestamp.

2

Value-based contracts with verifiable endpoints

Write outcome-based terms both sides can audit, including those under the CMS ACCESS Payer Pledge, which 14 plans covering 165 million Americans joined for January 2028.

Such agreements usually fail on measurement: completeness, attribution and timing are disputed months later. When the endpoint is written into the protocol before enrollment and recorded at its source, the contracted endpoint is the recorded endpoint. Verified conclusions, in pilot, will let both sides confirm results without exchanging records.

3

Benefit design for high-variance care

Direct members toward the sites and treatments the evidence supports, including GLP-1 therapy, where most patients without diabetes stop within a year.

Orthopedic, regenerative and device-heavy procedures show wide outcome variance that claims data cannot explain. Circles make site-level and treatment-level outcomes comparable, which supports center-of-excellence designation, tiering and prior-authorization criteria that hold up under appeal.

4

Prior authorization on evidence, not paperwork

Decide on one patient’s documented episode: diagnosis, prior treatment and its outcome, each entered by the treating clinician.

Authorization today asks a clinic to restate information the payer cannot verify. Where a site participates in a Circle, the relevant attributes already exist as attested records, and a proof can confirm a criterion is met without transmitting the chart. Review time falls and the audit trail improves.

5

Sponsored Circles in your own population

Commission the episode you need measured, and hold a defined share of the dataset it produces.

Rather than licensing broker-assembled extracts, a plan or self-insured employer can sponsor a Circle in a chosen indication across participating sites. RegenMed allocates the majority of the resulting Circles Dataset's license value to the Circle Members who produced it; consent rights remain with the patient and are recorded on Circle Health Coin.

By the numbers
52.8M
Medicare Advantage prior authorization determinations, 2024
80.7% of appealed denials were overturned
Jan 2028
ACCESS Payer Pledge
14 plans covering 165 million Americans commit to outcomes-based payment
$27.5B
Medicare Part D GLP-1 spending, 2024
64.8% of patients without diabetes stop within a year
0
Third-party data sources
Closed platform: every entry is made by the clinician or patient it describes

Sources: KFF (2026); CMS Innovation Center (2026); KFF (2026); Rodriguez et al., JAMA Network Open (2025); HHS OIG (2022).

Frequently asked questions
How is this different from the real-world data we already license?

Licensed data is assembled from claims and records after the fact, then cleaned, linked and modeled; its sources cannot be traced. A Circles Dataset records an episode defined before enrollment, including baseline and outcomes after discharge, with every entry attributable to the clinician or patient who made it.

Can we use a Circles Dataset in medical policy and appeals?

Yes. Each record carries the attesting clinician and time, and the endpoint was defined before any patient enrolled, so a policy or appeal decision can be defended item by item rather than cited in aggregate.

Do we need the provider to be on the platform?

The treating clinicians record through inCytes™; patients report through Benchmarc™ even when they do not return to care. A payer can sponsor a Circle among its network providers for the episode it needs measured.

What about member privacy and consent?

A record shared for a member’s prior authorization moves under HIPAA’s payment provisions. Datasets licensed for analysis are de-identified, and each patient’s consent terms stay attached to the data.

Pick one high-variance procedure and let the evidence settle it.

Talk to our team